3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Neoplasms
6
Pancreatic Neoplasms
3
Pancreatic Cyst
2
Wilms Tumor
1
Uveal Melanoma
1
Thyroid Nodule
1
Thyroid Diseases
1
Prostatic Neoplasms
1
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neuroendocrine Tumor
1
Hyperthyroidism
1
Hip Fractures
1
Hematologic Neoplasms
1
Goiter
1
Glioma
1
Glioblastoma
1
Frailty
1
Fractures, Spontaneous
1
Financial Stress
1
Interventions
Nivolumab
11
pembrolizumab
10
Ipilimumab
9
Cyclophosphamide
6
tebentafusp
5
Interleukin-2
4
Blood Specimen Collection
4
fludarabine phosphate
3
fludarabine
3
Specimen Handling
3
Radiosurgery
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
relatlimab
2
lenvatinib
2
cemiplimab
2
binimetinib
2
aflibercept
2
Surveys and Questionnaires
2
Dacarbazine
2
Crizotinib
2
Carmustine
2
Biopsy
2
ulixertinib
1
trametinib
1
sargramostim
1
ruxolitinib
1
omipalisib
1
olaparib
1
lifileucel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
Data Collection
×
1 year
×
Clear all
NCT06432660
2026-02-06
PROMPT
Duke University
Active not recruiting
42 enrolled